The Genetics of Pulmonary Fibrosis
Launched by UNIVERSITY OF COLORADO, DENVER · Mar 20, 2018
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "The Genetics of Pulmonary Fibrosis," is focused on studying a condition called Idiopathic Pulmonary Fibrosis (IPF), which causes scarring of the lungs and can make it hard to breathe. The main goal of the study is to check the first-degree family members (like children or siblings) of people with IPF for early signs of lung fibrosis, even if they don’t have symptoms yet. By identifying these signs early, the researchers hope to understand more about how this condition might develop in families.
To be eligible for the trial, participants must be at least 18 years old and have a family member who has been diagnosed with IPF. The study is currently recruiting participants of all genders. If you join the trial, you can expect to undergo tests that will help researchers learn more about the genetics of this disease. This information could be vital for understanding how IPF affects families and may lead to better treatments in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age at least 18 years old
- • Family member diagnosed with IPF
- Exclusion Criteria:
- • - No family member with IPF
About University Of Colorado, Denver
The University of Colorado, Denver, is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university conducts a diverse range of clinical trials aimed at addressing critical health challenges. Its research initiatives are supported by a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to ethical standards and patient safety. By fostering partnerships with local and global communities, the University of Colorado, Denver, strives to translate scientific discoveries into meaningful advancements in clinical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aurora, Colorado, United States
Patients applied
Trial Officials
David A Schwartz, MD
Principal Investigator
University of Colorado, Denver
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials